SSIONThe dismal outcome of individuals with CML-BC treated with either TKIs
SSIONThe dismal outcome of individuals with CML-BC treated with either TKIs or other experimental drugs reflects our lack of a clear understanding of which BCR-ABL kinasedependent and/or ndependent pathways are…